Protez Phamaceuticals

Protez Pharmaceuticals, Inc. develops antibiotics for the hospital market. Its product pipeline includes Protez, an antibiotic; PZ-601, a carbapenem antibiotic; The company's products are used in the treatment of drug-resistant and life-threatening infections. Protez Pharmaceuticals, Inc. was founded in 2003 and recently acquired by Novartis. Protez is a standalone subsidiary of Novartis headquartered in Malvern, Pennsylvania